Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Share By

Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology Publisher Pubmed

Samimi H¹ ; Haghpanah V^{1, 2, 3}

Source: Trends in Endocrinology and Metabolism Published:2020

Abstract

Gut microbiome (GM) might be associated with radioiodine (RAI)-refractory papillary thyroid carcinoma (PTC) through different mechanisms related to sodium/iodide (Na+/I–) symporter (NIS) regulation. However, whether thyroid carcinoma (TC), especially RAI-refractory PTC, causes dysbiosis, or vice versa, is still unknown. Further studies are needed to investigate the mechanism between GM and RAI-refractory PTC. © 2020 Elsevier Ltd

Related Docs

View other Related Docs

1. Our Little Friends With Big Roles: Alterations of the Gut Microbiota in Thyroid Disorders, Endocrine# Metabolic and Immune Disorders - Drug Targets (2020)

2. Molecular Evidence Reveals Thyrotropin Intervention Enhances the Risk of Developing Radioiodine-Refractory Differentiated Thyroid Carcinoma, Cancer Cell International (2022)

3. Evaluation of Etiology, Clinical Manifestations, Diagnosis, Follow-Up, Histopathology and Prognosis Factors in Papillary Thyroid Microcarcinoma: A Systematic Review and Meta-Analysis, Iranian Journal of Pathology (2023)

Experts (# of related papers)

View all Related Experts

Hanieh-Sadat Ejtahed (2)

Ahmadreza Soroush (1)

Other Related Docs

4. Gut Microbiota: A Perspective of Precision Medicine in Endocrine Disorders, Journal of Diabetes and Metabolic Disorders (2020)

5. Role of Gut Microbiota in the Pathogenesis of Colorectal Cancer; a Review Article, Gastroenterology and Hepatology from Bed to Bench (2018)

6. Microbiota and Probiotics, a New Approach in the Prevention and Treatment of Breast Cancer: A Review Article; [میکروبیوتا و پروبیوتیکها، رویکردی نوین در پیشگیری و درمان سرطان پستان: یک مقاله مروری], Tehran University Medical Journal (2024)

7. Probiotic Bacteria Cannot Mitigate the Adverse Effects of Radioactive Iodine-131 Treatment, Cancers (2023)

Style	Citing Format
MLA	Samimi H, Haghpanah V. "Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology." Trends in Endocrinology and Metabolism, vol. 31, no. 9, 2020, pp. 627-630.
APA	Samimi H, Haghpanah V (2020). Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology. Trends in Endocrinology and Metabolism, 31(9), 627-630.
Chicago	Samimi H, Haghpanah V. "Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology." Trends in Endocrinology and Metabolism 31, no. 9 (2020): 627-630.
Harvard	Samimi H, Haghpanah V (2020) 'Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology', Trends in Endocrinology and Metabolism, 31(9), pp. 627-630.
Vancouver	Samimi H, Haghpanah V. Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology. Trends in Endocrinology and Metabolism. 2020;31(9):627-630.
BibTex	@article{ author = {Samimi H and Haghpanah V}, title = {Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology}, journal = {Trends in Endocrinology and Metabolism}, volume = {31}, number = {9}, pages = {627-630}, year = {2020} }
RIS	TY - JOUR AU - Samimi H AU - Haghpanah V TI - Gut Microbiome and Radioiodine-Refractory Papillary Thyroid Carcinoma Pathophysiology JO - Trends in Endocrinology and Metabolism VL - 31 IS - 9 SP - 627 EP - 630 PY - 2020 ER -

Science Communicator Platform

Authors

Abstract